NEW YORK CITY, NY / ACCESS Newswire / November 9, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Simulations Plus, Inc. ("Simulations Plus" or the "Company") (NASDAQ:SLP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Simulations Plus and certain of its […]

NEW YORK CITY, NY / ACCESS Newswire / November 9, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Jumia Technologies AG ("Jumia" or the "Company") (NYSE:JMIA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Jumia and certain of its officers and/or

NEW YORK, NY / ACCESS Newswire / November 9, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Freshpet, Inc. ("Freshpet" or the "Company") (NASDAQ:FRPT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Freshpet and certain of its officers and/or directors have

NEW YORK CITY, NY / ACCESS Newswire / November 9, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed on behalf of investors in Class A, Class C, and/or Class I shares in the Wildermuth Fund (the "Fund") (NASDAQ:WESFX; WEFCX; WEIFX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com

NEW YORK CITY, NY / ACCESS Newswire / November 9, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Cepton, Inc. ("Cepton" or the "Company") (NASDAQ:CPTN) and certain officers.�� The class action, filed in the United States District Court for the Northern District of California, and docketed under 25-cv-08571, is

NEW YORK CITY, NY / ACCESS Newswire / November 9, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Camping World Holdings, Inc. ("Camping World" or the "Company") (NYSE:CWH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Camping World and certain of

NEW YORK CITY, NY / ACCESS Newswire / November 9, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Stride, Inc. ("Stride" or the "Company") (NYSE:LRN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Stride and certain of its officers and/or directors

NEW YORK CITY, NY / ACCESS Newswire / November 9, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Arcturus Therapeutics Holdings Inc. ("Arcturus" or the "Company") (NASDAQ:ARCT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Arcturus and certain of its officers

NEW YORK, NY / ACCESS Newswire / November 9, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Coty, Inc. ("Coty" or the "Company") (NYSE:COTY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Coty and certain of its officers and/or directors have

NEW YORK, NY / ACCESS Newswire / November 9, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. ("Inspire" or the "Company") (NYSE:INSP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are